Early Access — free while we kick the tires
EdgarHawk

HAUGHEY THOMAS

Director

Director
1 filing analyzed · 1 company · Latest 2025-08-14

Companies

Company Buys Sells Direction
ANI PHARMACEUTICALS INC ANIP 0 1 Net selling

Activity

August 2025
high
Sell
19,341 shares
$1,661,972
Significance 5/10

Director Thomas Haughey sold 19,341 shares of ANIP at $85.93, reducing holdings 34.6% to 36.5K shares ($1.7M value)

Director Thomas Haughey sold 19,341 shares at $85.93 on 2025-08-12, reducing his holdings from 55.9K to 36.5K shares—a 34.6% reduction in position size. The sale occurred as ANIP's stock approached its 52-week high of $90.00 and after substantial momentum (30-day change: +40.6%, 90-day change: +50.0%). The company reports strong recent fundamentals with $211.4M quarterly revenue and 26.2% annual revenue growth, though it was unprofitable over its most recent full fiscal year. The scale of the reduction—nearly one-third of holdings liquidated near multi-year highs following extended appreciation—merits investor attention, particularly given the company's profitability backdrop.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access